ABSTRACT
Hypertension (HT) is seen with increasing frequency in childhood. Various guidelines have been published to better evaluate these patients. The most frequently used of these are; The 4th Report (The 4th Report-2004) updated and published by the National Heart Lung and Blood Institute (NHLBI) National High Blood Pressure Education Program (NHBPEP) Working Group in 2004, a guideline prepared by the European Society of Hypertension in 2016 (ESH-2016), the last one is the guideline prepared by the American Academy of Pediatrics in 2017 (AAP-2017). Although these guidelines have some similarities, there are serious differences between them. The 4th Report-2004 and ESH-2016 guidelines use blood pressure (BP) percentile tables based on age and height previously determined in American children. Then, new tables were created by extracting the measurements of obese children and these tables were used in AAP-2017. From the age of 16 in ESH-2016 and 13 in AAP-2017, it is recommended that BP evaluations should be made according to adult guidelines. Evaluation of the hypertensive patient, Ambulatory Blood Pressure Monitoring (ABPM) criteria, the timing of laboratory tests and treatment differ according to guidelines. As a result; since universal BP tables covering all children around the world have not yet been created; age, ethnic and geographical conditions should be taken into account when evaluating which guidelines the office BP and ABPM should follow. By following the currently published guidelines, it will be possible to reduce future cardiovascular events.
References
1Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 2008;117:3171-80.
2BaoW, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking ofelevated blood pressure from childhood to adulthood: the Bogalusa heart study. AmJ Hypertens 995;6:657-65.
3Falkner B, Gidding SS, Portman R,Rosner B. Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics 2008;122:238-42.
4Rosner B, Cook NR, Daniels S,Falkner B. Childhood blood pressuretrends and risk factors for highblood ressure: the NHANES experience 1988-2008. Hypertension 2013;62:247-54.
5Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA 2007;298:874-9.
6Parker ED, Sinaiko AR, Kharbanda EO, Margolis KL, Daley MF, Trower NK, et al. Change in weight status and development of hypertension. Pediatrics 2016;137: e20151662
7Archbold KH, Vasquez MM, Goodwin JL, Quan SF. Effects of sleep patterns and obesity on increases in blood pressure in a 5-year period: report from the Tucson Children’s Assessment of Sleep Apnea Study. J Pediatr 2012;161:26-30.
8Au CT, Ho CK, Wing YK, Lam HS, Li AM. Acute and chronic effects of sleep duration on blood pressure. Pediatrics 2014;133.
9Shatat IF, Flynn JT. Hypertension in children with chronic kidney disease. Adv Chronic Kidney Dis 2005;12:378-84.
10Edvardsson VO, Steinthorsdottir SD, Eliasdottir SB, Indridason OS, Palsson R. Birth weight and childhood blood pressure. Curr Hypertens Rep 2012;14:596-602.
11National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2, suppl 4th Report):555-76.
12Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016;34:1887-920.
13Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Subcommittee on Screening and Management of High Blood Pressure in Children. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017;140:e20171904.
14Savoca MR, MacKey ML, Evans CD, Wilson M, Ludwig DA, Harshfield GA. Association of ambulatory blood pressure and dietary caffeine in adolescents. Am J Hypertens 2005;18:116-20.
15Wühl E, Witte K, Soergel M, Mehls O, Schaefer F; German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002;20:1995-2007.
16Samuel JP, Bell CS, Hebert SA, Varughese A, Samuels JA, Tyson JE. Office blood pressure measurement alone often misclassifies treatment status in children with primary hypertension.Blood Press Monit 2017;22:328-32.
17Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension 2014;63:1116-35.
18O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31:1731- 68.
19Andrade H, PiresA, Noronha N, Amaral ME, Lopes L,Martins P, et al. Importance of ambulatory blood pressure monitoring in the diagnosis and prognosis of pediatric hypertension. Rev Port Cardiol 2018;37:783-9.
20Cuspidi C, Sala C, Tadic M, Gherbesi E, De Giorgi A, Grassi G, et al. Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: an updated review. J Clin Hypertens (Greenwich) 2017;19:713-21.
21Krzych LJ, Szydlowski L. Determinants of inappropriate circadian blood pressure variability in children with essential hypertension. Can J Cardiol 2009;25:e13-6.
22Kupferman JC, Batisky DL, Samuels J, Adams HR, Hooper SR, Wang H, et al. Ambulatory blood pressure monitoring and neurocognitive function in children with primary hypertension. Pediatr Nephrol 2018;33:1765-71.
23Oliver Venettacci1 and Nicholas G. Larkins. Controversy and Agreement Among Guidelines Defining Ambulatory Hypertension in Children, Kidney Int Rep (2020) 5, 569-71.
24Stergiou GS, Nasothimiou EG, Giovas PP, Rarra VC. Long-term reproducibility of home vs. office blood pressure in children and adolescents: the Arsakeion school study. Hypertens Res 2009;32:311-5.
25Salgado CM, Jardim PC, Viana JK, Jardim TdeS, Velasquez PP. Home blood pressure in children and adolescents: a comparison with office and ambulatory blood pressure measurements. Acta Paediatr 2011;100:163-8.
26Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N.White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol 2005;20:1151-5.
27Sorof JM, Poffenbarger T, Franco K, Portman R. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens 2001;14:855-60.
28Siven SS, Niiranen TJ, Kantola IM, Jula AM. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study. J Hypertens 2016;34:54-60.
29Hager A, Kanz S, Kaemmerer H, Schreiber C, Hess J. Coarctation Long-term Assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg 2007;134:738-45.
30Di Salvo G, Castaldi B, Baldini L, Gala S, del Gaizo F, D’Andrea A, et al.Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function. J Hum Hypertens 2011;25:739-45.
31 Coleman DM, Eliason JL, Ohye RG, Stanley JC. Long-segment thoracoabdominal aortic occlusions in childhood. J Vasc Surg 2012;56:482-5.
32Gomes RS, Quirino IG, Pereira RM, et al. Primary versus secondary hypertension in children followed up at an outpatient tertiary unit. Pediatr Nephrol 2011;26:441-7.
33Lee BK, Ahn J, Kim NS, Lee CB, Park J, Kim Y. Association of blood pressure with exposure to lead and cadmium: analysis of data from the 2008-2013 Korean National Health and Nutrition Examination Survey. Biol Trace Elem Res 2016;174:40-51.
34Aglony M, Martinez-Aguayo A, Carvajal CA, Campino C, García H, Bancalari R, et al. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation. Hypertension 2011;57:1117-21.
35Kupferman JC, Paterno K, Mahgerefteh J, Pagala M, Golden M, Lytrivi ID, et al. Improvement of left ventricular mass with antihypertensive therapy in children with hypertension. Pediatr Nephrol 2010;25:1513-8.
36Litwin M, Niemirska A, Sladowska-Kozlowska J, Wierzbicka A, Janas R, Wawer ZT, et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol 2010;25:2489-99.
37Wuhl E, Trivelli A, Picca S, et al; ESCAPE Trial Group. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009;361:1639-50.
38Yang Q, Zhang Z, Kuklina EV, et al. Sodium intake and blood pressure among US children and adolescents. Pediatrics 2012;130:611-9.
39Damasceno MM, de Araujo MF, de Freitas RW, de Almeida PC, Zanetti ML. The association between blood pressure in adolescents and the consumption of fruits, vegetables and fruit juice--an exploratory study. J Clin Nurs 2011;20:1553-60.
40Croxtall JD. Valsartan: in children and adolescents with hypertension. Paediatr Drugs 2012;14:201-7 .
41Patel NH, Romero SK, Kaelber DC. Evaluation and management of pediatric hypertensive crises: hypertensive urgency and hypertensive emergencies. Open Access Emerg Med 2012;4:85-92.
